Bandingkan Harga & Kinerja GTS Internasional Tbk. (GTSI) vs Indofarma Tbk. (INAF)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan GTS Internasional Tbk. dan Indofarma Tbk.: GTS Internasional Tbk. diperdagangkan di Rp165 (kapitalisasi pasar 2,64 T, volume 24 jam 20,64 jt), sedangkan Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M). Perbedaan utamanya: GTS Internasional Tbk. jauh lebih besar — sekitar 6,8× kapitalisasi pasar Indofarma Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| GTSI | INAF | |
|---|---|---|
Kapitalisasi Pasar | 2,64 T | 390,51 M |
Volume | 20,64 jt | — |
Lot | 206,42 rb | — |
Perputaran | 3,34 M | — |
Harga Rata-rata | 161,78 | — |
Nilai Transaksi | 3,34 M | — |
Harga Ekuilibrium Indikatif | 165 | — |
Volume Ekuilibrium Indikatif | 4,9 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang GTS Internasional Tbk.
PT GTS Internasional Tbk (the “Company”) was established based on Notarial Deed No. 32 dated June 29, 2012 of Martina, S.H. The Company started its commercial operations in August 2019. The Company’s parent entity is PT Hateka Trans Internasional and ultimate parent entity is PT Humpuss Intermoda Transportasi Tbk.
Selengkapnya di halaman GTSI →Tentang Indofarma Tbk.
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Selengkapnya di halaman INAF →
